Diabetic Nephropathy.
Conditions
Interventions
Intervention 1: placebo for three months. Intervention 2: cap zinc sulfate : 30mg/daily for 3 months.
Placebo
Treatment - Drugs
placebo for three months
cap zinc sulfate : 30mg/daily for 3 months
Sponsors
Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Confirmed continuous albuminuria Exclusion criteria: Intake of any kind of vitamin supplements in recent months, Active urinary tract infections, increased liver enzymes more than 2 times, Allergic reactions to zinc, Failure to follow up, Any history of systemic inflammatory disorders or active infection, GFR below 30 ml / min, Hypogonadysm due to other reasons, Existence of proteinuria due to other reasons
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microalbominuria. Timepoint: at the beginning of the study and 3 months after intervention. Method of measurement: Immuno Turbidomethry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Glomerular Filtration Rate. Timepoint: at the begining of the study and 3month after intervention. Method of measurement: Based on this formula:GFR=140-BW×Age/p×72.;Sexual Function. Timepoint: at the beginning of the study and 3month after intervention. Method of measurement: Based on IIEF-5 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Faranak Sharifi
Zanjan Metabolic Diseases Research Center
Outcome results
None listed